Dataset from An Open-label Phase III, Multi-centre 52-week , Parallel-group Study Evaluating the Safety and Efficacy of Symbicort Turbuhaler 320/9 Twice Daily Compared With Standard Treatment in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)

The purpose of this study is to evaluate the safety and efficacy of Symbicort Turbuhaler compared to standard COPD treatment during one year in Japanese patients with COPD.

本研究旨在针对日本慢性阻塞性肺疾病（Chronic Obstructive Pulmonary Disease，COPD）患者，评估Symbicort Turbuhaler相较于标准COPD治疗方案在为期一年疗程中的安全性与有效性。